Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127600491 | 12760049 | 1 | I | 20160904 | 20160913 | 20160919 | 20160919 | EXP | US-009507513-1609USA007528 | MERCK | 59.00 | YR | F | Y | 0.00000 | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127600491 | 12760049 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 50 MG, ONCE A DAY | Y | 21995 | 50 | MG | FILM-COATED TABLET | QD | |||||
| 127600491 | 12760049 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | Y | 21995 | 100 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127600491 | 12760049 | 1 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127600491 | 12760049 | HO |
| 127600491 | 12760049 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127600491 | 12760049 | Myocardial infarction | |
| 127600491 | 12760049 | Product tampering | |
| 127600491 | 12760049 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127600491 | 12760049 | 2 | 20160904 | 0 |